TY  - GEN
AU  - Tartour,E
AU  - Mathiot,C
AU  - Fridman,W H
TI  - Current status of interleukin-2 therapy in cancer
SN  - 0753-3322
PY  - 1993///0809
KW  - Animals
KW  - Combined Modality Therapy
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - Interleukin-2
KW  - adverse effects
KW  - Killer Cells, Lymphokine-Activated
KW  - transplantation
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Neoplasms
KW  - immunology
KW  - Neoplasms, Experimental
KW  - drug therapy
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1016/0753-3322(92)90005-r
ER  -